Li X, Kim H, Yoo J, Lee Y, Nam C, Park J
Mol Cancer. 2025; 24(1):64.
PMID: 40033380
PMC: 11877783.
DOI: 10.1186/s12943-025-02273-2.
Hamed A, Hua K, Trinh Q, Simons B, Marioni J, Stein L
Nature. 2025; 638(8050):499-509.
PMID: 39743595
PMC: 11821533.
DOI: 10.1038/s41586-024-08356-2.
Dave B, Tailor J
BMC Cancer. 2024; 24(1):1465.
PMID: 39609728
PMC: 11603633.
DOI: 10.1186/s12885-024-13187-5.
Gao D, Liu D, Eastman A, Womack N, Ohene-Gambill B, Baez M
bioRxiv. 2024; .
PMID: 39484434
PMC: 11526988.
DOI: 10.1101/2024.10.20.619254.
Manescu Paltanea V, Antoniac I, Paltanea G, Nemoianu I, Mohan A, Antoniac A
Int J Mol Sci. 2024; 25(18).
PMID: 39337552
PMC: 11432100.
DOI: 10.3390/ijms251810065.
Rodent models of tumours of the central nervous system.
Brandner S
Mol Oncol. 2024; 18(12):2842-2870.
PMID: 39324445
PMC: 11619804.
DOI: 10.1002/1878-0261.13729.
Unravelling the mosaic: Epigenetic diversity in glioblastoma.
Lucchini S, Constantinou M, Marino S
Mol Oncol. 2024; 18(12):2871-2889.
PMID: 39148319
PMC: 11619803.
DOI: 10.1002/1878-0261.13706.
Unraveling glioblastoma diversity: Insights into methylation subtypes and spatial relationships.
Foltyn-Dumitru M, Alzaid H, Rastogi A, Neuberger U, Sahm F, Kessler T
Neurooncol Adv. 2024; 6(1):vdae112.
PMID: 39022646
PMC: 11253205.
DOI: 10.1093/noajnl/vdae112.
Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.
Bouley S, Grassetti A, Allaway R, Wood M, Hou H, Burdon Dasbach I
J Cell Sci. 2024; 137(15).
PMID: 39016685
PMC: 11361638.
DOI: 10.1242/jcs.262343.
Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.
Pan Y, Hysinger J, Yalcin B, Lennon J, Byun Y, Raghavan P
Nat Neurosci. 2024; 27(8):1555-1564.
PMID: 38816530
PMC: 11303248.
DOI: 10.1038/s41593-024-01654-y.
Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma.
Williams T, Nwokoye P, Kuc R, Smith K, Paterson A, Allinson K
Front Neurosci. 2024; 18:1379658.
PMID: 38803685
PMC: 11128631.
DOI: 10.3389/fnins.2024.1379658.
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges.
Mandorino M, Maitra A, Armenise D, Baldelli O, Miciaccia M, Ferorelli S
Cancers (Basel). 2024; 16(10).
PMID: 38791893
PMC: 11120159.
DOI: 10.3390/cancers16101814.
Glioblastoma modeling with 3D organoids: progress and challenges.
Wang X, Sun Y, Zhang D, Ming G, Song H
Oxf Open Neurosci. 2024; 2:kvad008.
PMID: 38596241
PMC: 10913843.
DOI: 10.1093/oons/kvad008.
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?.
Sloan A, Silver D, Kint S, Gallo M, Lathia J
Neuro Oncol. 2024; 26(5):785-795.
PMID: 38394444
PMC: 11066900.
DOI: 10.1093/neuonc/noae011.
Gliomas: a reflection of temporal gliogenic principles.
Sojka C, Sloan S
Commun Biol. 2024; 7(1):156.
PMID: 38321118
PMC: 10847444.
DOI: 10.1038/s42003-024-05833-2.
Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment.
Genoud V, Kinnersley B, Brown N, Ottaviani D, Mulholland P
Cancers (Basel). 2023; 15(24).
PMID: 38136335
PMC: 10741850.
DOI: 10.3390/cancers15245790.
Visual genetic typing of glioma using proximity-anchored in situ spectral coding amplification.
Chen X, Deng R, Su D, Ma X, Han X, Wang S
Exploration (Beijing). 2023; 3(5):20220175.
PMID: 37933281
PMC: 10582607.
DOI: 10.1002/EXP.20220175.
Neuron-oligodendroglial interactions in health and malignant disease.
Taylor K, Monje M
Nat Rev Neurosci. 2023; 24(12):733-746.
PMID: 37857838
PMC: 10859969.
DOI: 10.1038/s41583-023-00744-3.
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress.
Dewdney B, Jenkins M, Best S, Freytag S, Prasad K, Holst J
Signal Transduct Target Ther. 2023; 8(1):400.
PMID: 37857607
PMC: 10587102.
DOI: 10.1038/s41392-023-01637-8.
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment.
Cai Q, Li X, Xiong H, Fan H, Gao X, Vemireddy V
Nat Commun. 2023; 14(1):4934.
PMID: 37582846
PMC: 10427669.
DOI: 10.1038/s41467-023-40579-1.